Ardent Health Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Ardent Health stock has a consensus rating of "Buy" and an average price target of $12.05. The average 1-year stock price forecast is 12.93% higher than the current stock price, while the lowest is $9.00 (-15.65%) and the highest is $14 (+31.21%).

Price Target: $12.05 (+12.93%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$9.00	$12.05	$12	$14
Change	-15.65%	+12.93%	+12.46%	+31.21%

Analyst Ratings

The average analyst rating for Ardent Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	7	7	6	6	6	6
Buy	1	1	1	1	1	1
Hold	4	4	4	4	4	4
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	13	13	12	12	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kevin Fischbeck Bank of America Securities	Bank of America Securities	Sell Maintains $9.5 → $9	Sell	Maintains	$9.5 → $9	-15.65%	Jul 15, 2026
David S Macdonald Truist Financial	Truist Financial	Buy Maintains $13 → $12	Buy	Maintains	$13 → $12	+12.46%	Jul 14, 2026
Ben Hendrix RBC Capital	RBC Capital	Buy Maintains $13 → $12	Buy	Maintains	$13 → $12	+12.46%	Jul 9, 2026
Scott Fidel Goldman Sachs	Goldman Sachs	Hold Maintains $12	Hold	Maintains	$12	+12.46%	Jun 11, 2026
Craig Hettenbach Morgan Stanley	Morgan Stanley	Hold Maintains $12	Hold	Maintains	$12	+12.46%	Jun 8, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

6.44B

from 6.32B

1.85%

from 6.32B

Revenue Next Year

6.71B

from 6.44B

4.23%

from 6.44B

EPS This Year

1.29

from 1.54

-16.79%

from 1.54

EPS Next Year

1.25

from 1.29

-3.11%

from 1.29

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	4.87B	5.13B	5.41B	5.97B	6.32B	6.44B
Revenue Growth	17.02%	5.32%	5.45%	10.29%	6.01%	1.85%
Operating Income	303.17M	200.25M	215.84M	405.76M	325.58M	357.97M
Net Income	154.26M	188.91M	53.90M	210.34M	135.81M	148.61M
EPS	-	-	-	-	1.54	1.29
EPS Growth	-	-	-	-	-0.59%	-16.79%
Forward PE	-	-	-	8.79	6.83	8.30
Free Cash Flow	-	-	55.07M	50.07M	154.22M	9.00M
No. Analysts	-	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	6.5B
Avg	6.4B
Low	6.4B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	2.8%
Avg	1.8%
Low	1.2%

EPS Forecast

Chart

EPS	2026	2027	2028
High	1.48
Avg	1.29
Low	1.09

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-4.2%
Avg	-16.8%
Low	-29.4%